These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28097530)

  • 21. Clinical features of hepatitis B virus-related hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2010 May; 16(20):2463-7. PubMed ID: 20503445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?
    Abu-Amara M; Feld JJ
    Semin Liver Dis; 2013 May; 33(2):157-66. PubMed ID: 23749672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of hepatitis B virus-related hepatocellular carcinoma.
    Lok AS
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S303-9. PubMed ID: 15508098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis B and hepatocellular carcinoma].
    Sun AW; Chne YS; Li L
    Zhongguo Yi Miao He Mian Yi; 2010 Apr; 16(2):173-7. PubMed ID: 20575275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy.
    Halegoua-De Marzio D; Hann HW
    Minerva Gastroenterol Dietol; 2014 Sep; 60(3):191-200. PubMed ID: 25000955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus infection and the risk of hepatocellular carcinoma.
    Tan YJ
    World J Gastroenterol; 2011 Nov; 17(44):4853-7. PubMed ID: 22171125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary and secondary prevention of liver cancer caused by HBV.
    Blumberg BS
    Front Biosci (Schol Ed); 2010 Jan; 2(2):756-63. PubMed ID: 20036981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
    Pár A
    Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBV and liver cancer.
    Leung N
    Med J Malaysia; 2005 Jul; 60 Suppl B():63-6. PubMed ID: 16108176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus in hepatocarcinogenesis.
    Feitelson MA
    J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination.
    Kim MN; Han KH; Ahn SH
    Semin Oncol; 2015 Apr; 42(2):316-28. PubMed ID: 25843736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What surgeons should know about viral hepatitis and hepatocellular carcinoma.
    Hassoun Z; Gores GJ
    Surg Oncol Clin N Am; 2003 Jan; 12(1):1-11, vii. PubMed ID: 12735125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus-induced hepatocellular carcinoma.
    Xu C; Zhou W; Wang Y; Qiao L
    Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.